Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

323 ARTÍCULOS , VIENDO DEL 166 AL 180

A 12-week multidomain intervention versus active control to reduce risk of Alzheimer's disease: study protocol for a randomized controlled trial

Anstey KJ, Bahar-Fuchs A, Herath P, Rebok GW, Cherbuin N.

Trials. 2013 Feb 27;14:60. doi: 10.1186/1745-6215-14-60.

What can memory tests predict about the aging brain? The freedom to recall

Wright CB, Zonderman AB.

Neurology. 2013 Apr 2;80(14):1274-5. doi: 10.1212/WNL.0b013e31828ab392. Epub 2013 Mar 6.

A randomized, double-blind, placebo-controlled trial of memantine in a behaviorally enriched sample of patients with moderate-to-severe Alzheimer's disease

Herrmann N, Gauthier S, Boneva N, Lemming OM; 10158 Investigators.

Int Psychogeriatr. 2013 Jun;25(6):919-27. doi: 10.1017/S1041610213000239. Epub 2013 Mar 8.

Cerebrovascular reactivity to carbon dioxide in Alzheimer's disease

Glodzik L, Randall C, Rusinek H, de Leon MJ.

J Alzheimers Dis. 2013;35(3):427-40. doi: 10.3233/JAD-122011.

Cognitive impairment and diabetes

Dash SK.

Recent Pat Endocr Metab Immune Drug Discov. 2013 May;7(2):155-65. doi: 10.2174/1872214811307020009.

Psychiatry looks towards the future in neurodegenerative and neurodevelopmental disorders

Sachdev PS.

Curr Opin Psychiatry. 2013 May;26(3):237-8. doi: 10.1097/YCO.0b013e32835fd70e.

Utility of the AD8 as a self-rating tool for cognitive impairment in an Asian population

Chin R, Ng A, Narasimhalu K, Kandiah N.

Am J Alzheimers Dis Other Demen. 2013 May;28(3):284-8. doi: 10.1177/1533317513481090. Epub 2013 Mar 14.

Sex and ApoE genotype differences in treatment response to two doses of intranasal insulin in adults with mild cognitive impairment or Alzheimer's disease

Claxton A, Baker LD, Wilkinson CW, Trittschuh EH, Chapman D, Watson GS, Cholerton B, Plymate SR, Arbuckle M, Craft S.

J Alzheimers Dis. 2013;35(4):789-97. doi: 10.3233/JAD-122308.

Neurodegenerative disease phenotypes in carriers of MAPT p.A152T, a risk factor for frontotemporal dementia spectrum disorders and Alzheimer disease

Lee SE, Tartaglia MC, Yener G, Genç S, Seeley WW, Sanchez-Juan P, Moreno F, Mendez MF, Klein E, Rademakers R, López de Munain A, Combarros O, Kramer JH, Kenet RO, Boxer AL, Geschwind MD, Gorno-Tempini ML, Karydas AM, Rabinovici GD, Coppola G, Geschwind DH, Miller BL.

Alzheimer Dis Assoc Disord. 2013 Oct-Dec;27(4):302-9. doi: 10.1097/WAD.0b013e31828cc357.

Agitation and aggression in people with Alzheimer's disease

Ballard C, Corbett A.

Curr Opin Psychiatry. 2013 May;26(3):252-9. doi: 10.1097/YCO.0b013e32835f414b.

Benzodiazepine and dementia: a time for reflection

Bocti C, Roy-Desruisseaux J, Hudon C, Roberge P.

Maturitas. 2013 Jun;75(2):105-6. doi: 10.1016/j.maturitas.2013.03.001. Epub 2013 Mar 26.

The mini-Kingston Standardized Cognitive Assessment

Hopkins RW, Kilik LA.

Am J Alzheimers Dis Other Demen. 2013 May;28(3):239-44. doi: 10.1177/1533317513481095. Epub 2013 Mar 28.

"Will I get Alzheimer disease?" when cognitively normal patients ask to be tested for Alzheimer disease

Snider BJ, Buckles VD.

Continuum (Minneap Minn). 2013 Apr;19(2 Dementia):470-4. doi: 10.1212/01.CON.0000429171.50686.07.

Patient management problem

Pierce A.

Continuum (Minneap Minn). 2013 Apr;19(2 Dementia):519-37. doi: 10.1212/01.CON.0000429166.97320.81.

[Assessment of mild cognitive impairment and dementia in epidemiologic studies. An overview on the current state of research in Germany]

Then FS, Luck T, Jacobi F, Berger K, Weyerer S, Grabe HJ, Busch MA, Wagner M, Riedel-Heller SG.

Psychiatr Prax. 2013 May;40(4):183-91. doi: 10.1055/s-0033-1343138. Epub 2013 Apr 5.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias